Absolute Eosinophil Count Calculator

Absolute Eosinophil Count Calculator for Hematology. Reference ranges place a normal AEC below roughly 500 cells/µL. Values of 500–1,500 cells/µL indicate mild eosinophilia, most often reactive (allergy, drugs, parasites). An AEC above 1,500 cells/µL constitutes hypereosinophilia (HE) when documented on two occasions at least one month apart, or when marked tissue eosinophilia is present. HE is graded as moderate (1,500–5,000) or severe (>5,000 cells/µL); higher and more persistent counts raise concern for a primary/clonal or idiopathic process and for organ damage. Hypereosinophilic syndrome (HES) is diagnosed when HE coexists with eosinophil-mediated end-organ damage such as cardiac, pulmonary, neurologic, or dermatologic injury. Counts above 1,500 cells/µL, especially if rising or persistent, should trigger evaluation for cause (peripheral smear, tryptase, IgE, cardiac troponin/echo, and molecular testing for FIP1L1-PDGFRA and related fusions).

How this calculator works

The absolute eosinophil count (AEC) converts the eosinophil percentage from a differential into a concrete cell density by multiplying the total white blood cell count by the eosinophil fraction: AEC (cells/µL) = total WBC (cells/µL) × (eosinophil % ÷ 100). It reports how many eosinophils actually circulate per microliter rather than their relative share of leukocytes, which matters because a normal-looking percentage can hide true eosinophilia when the WBC is high, and a high percentage can be trivial when the WBC is low. Only the absolute value should be used for diagnostic thresholds; the percentage alone is misleading.

When to use this calculator

Use the AEC whenever a CBC differential is available and eosinophil-driven disease is on the differential: suspected drug reactions (including DRESS), parasitic infection, atopic and allergic disease, eosinophilic gastrointestinal disorders, EGPA/vasculitis, and the myeloid/lymphoid neoplasms that cause clonal eosinophilia. It is also the number tracked serially to gauge response to corticosteroids, anti-IL-5 biologics (mepolizumab, benralizumab), or imatinib in PDGFRA-rearranged disease. It should not be read off the percentage in isolation, and a single elevated value is not sufficient to diagnose hypereosinophilia, which requires persistence.

Inputs used

  • White blood cell count
  • Eosinophil percentage

Clinical interpretation

Reference ranges place a normal AEC below roughly 500 cells/µL. Values of 500–1,500 cells/µL indicate mild eosinophilia, most often reactive (allergy, drugs, parasites). An AEC above 1,500 cells/µL constitutes hypereosinophilia (HE) when documented on two occasions at least one month apart, or when marked tissue eosinophilia is present. HE is graded as moderate (1,500–5,000) or severe (>5,000 cells/µL); higher and more persistent counts raise concern for a primary/clonal or idiopathic process and for organ damage. Hypereosinophilic syndrome (HES) is diagnosed when HE coexists with eosinophil-mediated end-organ damage such as cardiac, pulmonary, neurologic, or dermatologic injury. Counts above 1,500 cells/µL, especially if rising or persistent, should trigger evaluation for cause (peripheral smear, tryptase, IgE, cardiac troponin/echo, and molecular testing for FIP1L1-PDGFRA and related fusions).

Worked example

A patient has a total WBC of 12,000 cells/µL with 18% eosinophils on the differential. AEC = 12,000 × 0.18 = 2,160 cells/µL. This exceeds 1,500 cells/µL, so it meets the threshold for hypereosinophilia if confirmed on a repeat count at least one month later. If this patient also had biopsy-proven eosinophilic myocarditis or restrictive cardiomyopathy attributable to eosinophils, the picture would satisfy hypereosinophilic syndrome (HE plus eosinophil-mediated organ damage), prompting urgent workup for a clonal versus reactive cause.

Limitations and safety notes

The AEC is subject to pronounced diurnal variation (typically lowest in the morning under the influence of endogenous cortisol) and is acutely suppressed by corticosteroids, acute infection, and stress, so a normal value drawn during a steroid course or acute illness does not exclude an eosinophilic disorder. Automated analyzers can miscount eosinophils in the presence of degranulation, marked leukocytosis, or interfering cells, warranting manual smear confirmation at extreme values. Critically, the peripheral count can be normal despite substantial tissue eosinophilia (as in some eosinophilic esophagitis and EGPA cases), so a normal AEC never rules out organ-based eosinophilic disease.

Frequently asked questions

Why use the absolute count instead of the eosinophil percentage?

The percentage depends on the total white cell count, so it can mislead in both directions. A patient with 4% eosinophils but a WBC of 40,000 has an AEC of 1,600 (true hypereosinophilia), while 15% eosinophils on a WBC of 2,000 is only 300 cells/µL (normal). Diagnostic thresholds are defined on the absolute value alone.

What count defines hypereosinophilia versus just eosinophilia?

Mild eosinophilia is 500–1,500 cells/µL. Hypereosinophilia (HE) requires an AEC above 1,500 cells/µL, confirmed on two occasions at least a month apart, or documented marked tissue eosinophilia. HE is graded moderate (1,500–5,000) or severe (>5,000).

What is the difference between hypereosinophilia and hypereosinophilic syndrome?

Hypereosinophilia is the laboratory finding (AEC >1,500/µL, persistent). Hypereosinophilic syndrome (HES) adds eosinophil-mediated organ damage, such as cardiac, pulmonary, neurologic, gastrointestinal, or skin injury attributable to the eosinophilia. HES demands prompt cause-directed evaluation and treatment.

Can the count be normal in a patient who truly has eosinophilic disease?

Yes. Corticosteroids, acute infection, and stress suppress circulating eosinophils, and conditions like eosinophilic esophagitis or EGPA can show heavy tissue eosinophilia with a normal or near-normal blood count. A normal AEC does not exclude organ-based disease.

References

  • Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130(3):607-612.e9. PMID: 22460074.
  • Valent P, Klion AD, Roufosse F, et al. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Allergy. 2022;78(1):47-59. PMID: 36207764.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: May 8, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators